Evidence map›Paper›PMID 35673506›Full record

ArticleJournal of diabetes and metabolic disorders2022

Role of metabolizing MTHFR gene polymorphism (rs1801133) and its mRNA expression among Type 2 Diabetes.

Divya Pathak, Dharmsheel Shrivastav, Amit K Verma, Abdulrahman A Alsayegh, Prasant Yadav, Nawaid Hussain Khan, Alhanouf I Al-Harbi, Mohammad Idreesh Khan, Kapil Bihade, Desh Deepak Singh and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Divya Pathak *Central Drugs Standard Control Organisation, New Delhi, India.
Dharmsheel Shrivastav *Amity Institute of Biotechnology, Amity University, Rajasthan Jaipur, India.
Amit K Verma *Department of Zoology and Environmental Sciences, GKV, Haridwar, India.
Abdulrahman A AlsayeghDepartment of Clinical Nutrition, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Prasant YadavDepartment of Biochemistry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh India.
Nawaid Hussain KhanFaculty of Medicine, Alatoo International University, Bishkek, Kyrgyzstan.
Alhanouf I Al-HarbiDepartment of Medical Laboratory, College of Applied Medical Sciences, Taibah University, Yanbu, Saudi Arabia.
Mohammad Idreesh KhanDepartment of Clinical Nutrition, College of Applied Health Sciences in Arras, Qassim University, Buraydah, Saudi Arabia.
Kapil BihadeDepartment of Accident and Emergency, Lok Nayak Hospital, New Delhi, India.
Desh Deepak SinghAmity Institute of Biotechnology, Amity University, Rajasthan Jaipur, India.
Mirza Masroor Ali BegFaculty of Medicine, Alatoo International University, Bishkek, Kyrgyzstan.
Ala-Too International University · KGAll India Institute of Medical Sciences Bhopal · INGurukul Kangri Vishwavidyalaya · INJazan University · SALok Nayak Jai Prakash Narayan Hospital · INNational AIDS Control Organisation · INQassim University · SATaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Type 2 Diabetes is a glucose metabolic disorder occurred by insulin insensitivity in which folate metabolism plays an important role. it is believed that polymorphism of Methylenetetrahydrofolate reductase (MTHFR) C677T linked with type 2 diabetes mellitus. However, results are conflicted. therefore, in this study we re-examine the relationship between MTHFR C677T in type 2 diabetes mellitus patients. Methods: Present research work included 100 newly diagnosed type 2 diabetic mellitus (T2DM) cases and 100 healthy individuals. After the blood sample collection all the biochemical parameters were evaluated among the T2DM cases and healthy individuals. DNA and RNA extraction from whole blood was done to study the MTHFR gene polymorphism by allele specific polymerase chain reaction method and its expression analysis was done by quantitative real time polymerase chain reaction method. Results: The significant difference was observed in genotype distribution among case and control group ( Conclusion: Our results indicates that the polymorphism in MTHFR C677T plays significant role in type II diabetes risk. MTHFR CT heterozygous and mutant TT genotype showed reduced mRNA expression among the T2DM patients. However, large scale case-control studies are needed to strengthen such conclusion in the future.

Indexed as

Diabetes mellitusMethylenetetrahydrofolate reductasePolymorphismQuantification RT-PCR

Identifiers

PMID35673506
PMCPMC9167251
OpenAlexW4212989811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.